Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.19.3.a.u2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Treasury Stock
Total
Balance at Mar. 31, 2018 $ 57 $ 889,585 $ (862,224) $ (1,658) $ 25,760
Balance (in shares) at Mar. 31, 2018 5,706,260     14,596  
Increase (Decrease) in Stockholders' Equity          
Purchase of treasury stock       $ (3) (3)
Purchase of treasury stock (in shares)       168  
Vested restricted stock awards   3     3
Vested restricted stock awards (in shares) 469        
Stock-based compensation   227     227
Warrants exercised $ 3 4,967     4,970
Warrants exercised (in shares) 346,691        
Issuance of common stock, net of issuance costs $ 4 (4)      
Issuance of common stock, net of issuance costs (in shares) 380,621        
Net loss     (4,898)   (4,898)
Balance at Jun. 30, 2018 $ 64 894,778 (867,122) $ (1,661) 26,059
Balance (in shares) at Jun. 30, 2018 6,434,041     14,764  
Balance at Mar. 31, 2018 $ 57 889,585 (862,224) $ (1,658) 25,760
Balance (in shares) at Mar. 31, 2018 5,706,260     14,596  
Increase (Decrease) in Stockholders' Equity          
Net loss         (12,704)
Balance at Dec. 31, 2018 $ 72 901,262 (874,929) $ (1,731) 24,674
Balance (in shares) at Dec. 31, 2018 7,180,348     21,021  
Balance at Jun. 30, 2018 $ 64 894,778 (867,122) $ (1,661) 26,059
Balance (in shares) at Jun. 30, 2018 6,434,041     14,764  
Increase (Decrease) in Stockholders' Equity          
Purchase of treasury stock       $ (70) (70)
Purchase of treasury stock (in shares)       6,254  
Vested restricted stock awards   70     70
Vested restricted stock awards (in shares) 330        
Stock-based compensation   224     224
Exercise of stock options and employee stock purchases   1     1
Exercise of stock options and employee stock purchases (in shares) 102        
Stock awards to Board of Directors   (70)     (70)
Stock awards to Board of Directors (in shares) 45,719        
Issuance of common stock, net of issuance costs $ 4 3,105     3,109
Issuance of common stock, net of issuance costs (in shares) 301,608        
Net loss     (4,357)   (4,357)
Balance at Sep. 30, 2018 $ 68 898,108 (871,479) $ (1,731) 24,966
Balance (in shares) at Sep. 30, 2018 6,781,800     21,018  
Increase (Decrease) in Stockholders' Equity          
Purchase of treasury stock (in shares)       3  
Vested restricted stock awards (in shares) 12,090        
Stock-based compensation   292     292
Issuance of common stock, net of issuance costs $ 4 2,862     2,866
Issuance of common stock, net of issuance costs (in shares) 386,458        
Net loss     (3,450)   (3,450)
Balance at Dec. 31, 2018 $ 72 901,262 (874,929) $ (1,731) 24,674
Balance (in shares) at Dec. 31, 2018 7,180,348     21,021  
Balance at Mar. 31, 2019 $ 7 903,803 (878,884) $ (1,772) 23,154
Balance (in shares) at Mar. 31, 2019 7,216,910     26,239  
Increase (Decrease) in Stockholders' Equity          
Purchase of treasury stock (in shares)       78  
Vested restricted stock awards (in shares) 229        
Stock-based compensation   262     262
Issuance of common stock, net of issuance costs $ 1 1,221     1,222
Issuance of common stock, net of issuance costs (in shares) 143,387        
Net loss     (5,593)   (5,593)
Balance at Jun. 30, 2019 $ 8 905,286 (884,477) $ (1,772) 19,045
Balance (in shares) at Jun. 30, 2019 7,360,526     26,317  
Balance at Mar. 31, 2019 $ 7 903,803 (878,884) $ (1,772) 23,154
Balance (in shares) at Mar. 31, 2019 7,216,910     26,239  
Increase (Decrease) in Stockholders' Equity          
Deemed dividend on purchase warrant for common shares         75
Net loss         (14,948)
Balance at Dec. 31, 2019 $ 9 912,097 (893,907) $ (1,816) 16,383
Balance (in shares) at Dec. 31, 2019 8,841,634     36,724  
Balance at Jun. 30, 2019 $ 8 905,286 (884,477) $ (1,772) 19,045
Balance (in shares) at Jun. 30, 2019 7,360,526     26,317  
Increase (Decrease) in Stockholders' Equity          
Purchase of treasury stock       $ (26) (26)
Purchase of treasury stock (in shares)       3,987  
Vested restricted stock awards   26     26
Vested restricted stock awards (in shares) 1,250        
Stock-based compensation   104     104
Exercise of stock options and employee stock purchases   3     3
Exercise of stock options and employee stock purchases (in shares) 522        
Stock awards to Board of Directors   (24)     (24)
Stock awards to Board of Directors (in shares) 26,315        
Issuance of common stock, net of issuance costs   4,815     4,815
Issuance of common stock, net of issuance costs (in shares) 616,443        
Deemed dividend on purchase warrant for common shares   75 (75)    
Net loss     (4,448)   (4,448)
Balance at Sep. 30, 2019 $ 8 910,285 (889,000) $ (1,798) 19,495
Balance (in shares) at Sep. 30, 2019 8,005,056     30,304  
Increase (Decrease) in Stockholders' Equity          
Purchase of treasury stock       $ (18) (18)
Purchase of treasury stock (in shares)       6,420  
Vested restricted stock awards   17     17
Vested restricted stock awards (in shares) 19,961        
Stock-based compensation   303     303
Warrants exercised $ 1       1
Warrants exercised (in shares) 440,000        
Issuance of common stock, net of issuance costs   1,201     1,201
Issuance of common stock, net of issuance costs (in shares) 376,617        
Change in warrants valuation   291     291
Net loss     (4,907)   (4,907)
Balance at Dec. 31, 2019 $ 9 $ 912,097 $ (893,907) $ (1,816) $ 16,383
Balance (in shares) at Dec. 31, 2019 8,841,634     36,724